Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Healthlead PCLBKK:HL +1.83%71 Receivables Turnover is 95.95 as of Mar. 2026. GuruFocus rates BKK:HL with a GF Score™ of 71/100 and a GF Value™ of ฿10.98 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Healthlead PCL ranks better than 98.94% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Healthlead PCL's Revenue for the
three
months ended in Mar. 2026 was ฿585 Mil. Healthlead PCL's average Accounts Receivable for the
three
months ended in Mar. 2026 was ฿6 Mil.
Hence, Healthlead PCL's Receivables Turnover for the
three
months ended in Mar. 2026 was 95.95.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Healthlead PCL Receivables Turnover Related Terms
Healthlead PCL Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Healthlead PCL's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Healthlead PCL's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthlead PCL Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Healthlead PCL's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Healthlead PCL's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthlead PCL (BKK:HL) has a Receivables Turnover of 95.95 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Healthlead PCL and its competitors. According to the industry distribution chart, Healthlead PCL ranks #7 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 1.1%.
Is Healthlead PCL's Receivables Turnover too high?
Healthlead PCL's current Receivables Turnover is 95.95. The Healthcare Providers & Services industry median Receivables Turnover is 7.94. Healthlead PCL's value of 95.95 is 1108.4% above this industry median. Based on the distribution chart, Healthlead PCL ranks #7 out of 659 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Healthlead PCL has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthlead PCL's Receivables Turnover compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Healthlead PCL ranks #7 out of 659 companies for Receivables Turnover. This places Healthlead PCL in the top 1% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 7.94. Healthlead PCL's value of 95.95 is 1108.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.94, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthlead PCL's current Receivables Turnover of 95.95 is 1108.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Healthlead PCL and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthlead PCL's current Receivables Turnover is 95.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthlead PCL stock overvalued right now?
Based on GuruFocus' analysis, Healthlead PCL (BKK:HL) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿10.98, compared to a current price of ฿5.55 — trading 49.5% below its estimated fair value. The current Receivables Turnover is 95.95 and 1108.4% above the Healthcare Providers & Services industry median of 7.94. Healthlead PCL's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Healthlead PCL (BKK:HL), the current Receivables Turnover is 95.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthlead PCL (BKK:HL) Overvalued in 2026?
Based on GuruFocus' analysis, Healthlead PCL stock appears to be undervalued.
The current stock price of ฿5.55 is trading 49.5% below its estimated GF Value™ of ฿10.98.
GuruFocus considers Healthlead PCL to be Significantly Undervalued.
Key valuation signals for BKK:HL:
Receivables Turnover: 95.95
GF Value™: ฿10.98 vs. price of ฿5.55 (49.5% below fair value)
Industry Position: 1108.4% above the Healthcare Providers & Services median (#7 of 659)
No single metric tells the full story. See the BKK:HL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthlead PCL is a holding company. Along with its subsidiaries, it operates a pharmacy business under iCare, Pharmax, vitaminclub, and Super Drug brands, distributing medicines, medical supplies, cosmeceuticals, dietary supplements, medical devices, and other healthcare products. Additionally, it is involved in co-inventing and co-developing healthcare products in collaboration with external research teams and contract manufacturers, producing and distributing its own branded products. Geographically, the group operates only in Thailand.
71GF Score
Get the complete analysis for BKK:HL
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:HL has been successfully added to your 
